Today on DrugResearcher.com   Apitope vaccine stops MS in its tracks Why Pfizer's torcetrapib failure might not thwart other CETP inhibitors Mass spectrometry weighs in for genotyping applications Charles River sails through Q3 Tecan and GE join forces to aid HT protein purification

Related Industry News   Cash injection for anthrax jab Satraplatin ruling in GPC Biotech favour New safety warning delays Novartis diabetes drug Icon improves its position, Kendle slips again

Breaking News on Drug Discovery
Daily  Tuesday 06 November 2007		Forward to a colleague

	Technical / White Paper Manufacturing Variations in Polysorbate Batches Lot to lot variances in a series of Polysorbate preparations was easily and clearly differentiated and identified by utilizing charged aerosol detection (CAD), a new universal detectorfor HPLC... Click Here Access Full Stories Apitope vaccine stops MS in its tracks UK biopharmaceutical firm Apitope has developed a vaccine that could halt multiple sclerosis in its relentless march to destroy nerve cells... Read Why Pfizer's torcetrapib failure might not thwart other CETP inhibitors It was supposed to keep Pfizer at the top of the cardiovascular drug tree, but when torcetrapib failed, other pharma firms developing similar drugs looked on nervously to see if their drugs were also doomed. A... Read Mass spectrometry weighs in for genotyping applications Commonly the domain of the microarray, mass spectrometry is becoming an increasingly viable alternative for high throughput genotyping with recent research promising to advance its adoption... Read Charles River sails through Q3 Charles River Laboratories sailed through its third quarter, with comfortable gains in both revenue and profits... Read Tecan and GE join forces to aid HT protein purification Tecan and GE Healthcare Life Sciences division are collaborating to simplify high throughput (HT) protein purification by increasing the speed and reliability of expression screening programmes... Read
	All News Headlines for: November | October | September
	Product Brochure Innovative New Shaking Incubator from Stuart® A compact bench top incubator can be just enough for bacterial cell culturing. The latest shaking incubator from Stuart® is packed with novel features such as BioCote antimicrobial protection:... Click Here
	Related Industry News Cash injection for anthrax jab US firms Medarex and PharmAthene today announced that they are to receive additional funding from the US Government to support the ongoing development of their anthrax therapeutic, Valortim... Read Satraplatin ruling in GPC Biotech favour GPC Biotech has found a ray of light in the satraplatin quagmire following an arbitration ruling in favour of the Germany-based biopharmaceutical company... Read New safety warning delays Novartis diabetes drug Swiss firm Novartis today announced that it has contacted regulators regarding the safety of the 100mg dose of its recently approved Type II diabetes drug, Galvus (vildagliptin)... Read Icon improves its position, Kendle slips again Icon has improved its financial position significantly during its third quarter, while its smaller US rival Kendle saw its profit slip again, weighed down by charges from a 2006 acquisition... Read Weekly Comment Big pharma lends a helping hand Despite often attracting a barrage of negative publicity, particularly in regard to a perception of putting profits before people, big pharma firms are still capable of showing their human side in times of crisis. Read Product Presentation Rapid HPLC method development with ChromSword®Auto software Avoid the tedious search for good HPLC methods for separation with ChromSword®Auto's quicker chromatography solutions... Click Here Previous Headlines EU considers Afghan poppy pilot A proposed pilot programme to divert Afghanistan's infamous and illegal opium supply for legal use in analgesics has been backed by the European Parliament but is facing fierce criticism elsewhere... Read Pretender to Avastin throne poised to enter clinical trails BioInvent and ThromboGenics' new anticancer antibody is poised to enter clinical trials and could prove a serious rival to VEGF-blocking drugs, due to fewer side-effects and less drug resistance... Read Mixed results dampen expectations for Eli Lilly's prasugrel When it comes to choosing between anti-blood clot medicines, clinicians could be stuck between a rock and a hard place following mixed trial results for Eli Lilly's prasugrel... Read Sigma-Aldrich halves miRNA preparation times Sigma-Aldrich has continued its push into the RNAi field with the launch of its new mirPremier miRNA (microRNA) isolation kit that promises to speed up miRNA preparation while removing all large, unwanted RNA... Read Pharma must 'reinvent' itself to survive With IMS Health's annual forecast for the pharma industry predicting slower approvals, more black box warnings and the continuation of the 'wave of genericization,' the shift by pharma firms to refocus and reinvent... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Manufacturing Variations in Polysorbate Batches - Technical / White Paper Product Information - brochures, Web centers ZIC®-HILIC Separation of Polar and Hydrophilic Compounds - Product Presentation DAICEL chiral chromatography products - Company Profile Rapid HPLC method development with ChromSword®Auto software - Product Presentation Separation of polar compounds - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com